BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$3.58B |
| 2 |
Microsoft
MSFT
|
+$3.36B |
| 3 |
GE Vernova
GEV
|
+$2.86B |
| 4 |
CRH
CRH
|
+$2.57B |
| 5 |
Amazon
AMZN
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$4.23B |
| 2 |
GE Aerospace
GE
|
+$1.37B |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$1.23B |
| 4 |
Super Micro Computer
SMCI
|
+$1.17B |
| 5 |
AbbVie
ABBV
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.27% |
| 2 | Healthcare | 12.09% |
| 3 | Financials | 11.69% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4576
SeaStar Medical
ICU
$12.5M
| $69.3K | ﹤0.01% |
913
+1
| +0.1% | +$107 |
|
4577
iShares US Medical Devices ETF
IHI
$3.13B
| $69.3K | ﹤0.01% |
1,236
-271
| -18% | -$15.2K |
|
|
CD
4578
Chaince Digital Holdings
CD
$222M
| $68.9K | ﹤0.01% |
+32,819
| New | +$47.7K |
|
4579
Dare Bioscience
DARE
$18.3M
| $68.4K | ﹤0.01% |
16,969
-16,039
| -49% | -$77.7K |
|
4580
Intensity Therapeutics
INTS
$11.2M
| $68.1K | ﹤0.01% |
556
+127
| +30% | +$14.4K |
|
4581
Optex Systems
OPXS
$78.6M
| $67.6K | ﹤0.01% |
+9,362
| New | +$70.6K |
|
4582
Imunon
IMNN
$6.68M
| $67.5K | ﹤0.01% |
4,464
| – | – |
|
4583
Innoviz Technologies
INVZ
$95M
| $67.4K | ﹤0.01% |
72,718
-729,217
| -91% | -$818K |
|
4584
ImmuCell
ICCC
$101M
| $66.8K | ﹤0.01% |
13,764
-1,091
| -7% | -$5.25K |
|
4585
AYTU BioPharma
AYTU
$23.9M
| $66.6K | ﹤0.01% |
22,793
| – | – |
|
|
OMCC
4586
DELISTED
Old Market Capital Corp
OMCC
| $66.5K | ﹤0.01% |
10,120
-426
| -4% | -$2.83K |
|
|
DHAI
4587
DELISTED
DIH Holdings US
DHAI
| $65.8K | ﹤0.01% |
+987
| New | +$43.3K |
|
4588
Natural Alternatives International
NAII
$14.4M
| $65.7K | ﹤0.01% |
10,921
-840
| -7% | -$5.46K |
|
4589
Boxlight
BOXL
$2.03M
| $65.7K | ﹤0.01% |
597
| – | – |
|
4590
Biomerica
BMRA
$4.6M
| $65.6K | ﹤0.01% |
18,635
| – | – |
|
|
FAT
4591
DELISTED
FAT Brands
FAT
| $64.6K | ﹤0.01% |
+22,585
| New | +$79.3K |
|
|
SPRB
4592
Spruce Biosciences
SPRB
$118M
| $64.6K | ﹤0.01% |
1,663
-816
| -33% | -$43.7K |
|
4593
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.08B
| $64.2K | ﹤0.01% |
+2,082
| New | +$64.1K |
|
4594
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
| $64.2K | ﹤0.01% |
1,281
-15,369
| -92% | -$769K |
|
4595
Direct Digital Holdings
DRCT
$1.89M
| $64.1K | ﹤0.01% |
72
-20
| -22% | -$24.6K |
|
|
ICD
4596
DELISTED
Independence Contract Drilling, Inc.
ICD
| $63.6K | ﹤0.01% |
48,935
-14,062
| -22% | -$23K |
|
4597
GameSquare
GAME
$34.6M
| $63.3K | ﹤0.01% |
52,789
+30,929
| +141% | +$44K |
|
4598
Data Storage Corp
DTST
$7.13M
| $63.1K | ﹤0.01% |
+9,614
| New | +$56.8K |
|
4599
Armata Pharmaceuticals
ARMP
$167M
| $63K | ﹤0.01% |
22,921
-947
| -4% | -$2.7K |
|
4600
Xilio Therapeutics
XLO
$59.9M
| $62.9K | ﹤0.01% |
4,744
+1,504
| +46% | +$23.5K |
|
Similar funds
BlackRock's Q2 2024 Portfolio in Review
As of Q2 2024, BlackRock held 5,453 positions worth $4.42T, up 2.9% from $4.3T the previous quarter. Its ten largest holdings account for 27% of the portfolio.
BlackRock's Q2 2024 filing shows 174 new, 2,441 increased, 2,110 reduced and 172 closed positions. Its largest new stake was Solventum: 11,038,924 shares worth $584M. The largest sale was Pioneer Natural Resource Co., an estimated $4.23B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2024 buy was Solventum: 11,038,924 shares worth $584M.
- BlackRock added most to ExxonMobil in Q2 2024, an estimated $3.58B increase.
- BlackRock's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $1.37B.
- BlackRock fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $4.23B.
- BlackRock's ten largest holdings make up 27% of its $4.42T portfolio in Q2 2024.
- BlackRock opened 174 new positions and closed 172 in Q2 2024.
- BlackRock's portfolio value rose 2.9% quarter-over-quarter to $4.42T.
Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.